All lobbying filings
LMH Strategic Solutions
LMH Strategic Solutions filed a Q2 report for Stealth Biotherapeutics Inc. on July 15, 2025, reporting $30,000 in lobbying income.
Lobbying for Stealth Biotherapeutics Inc. · Biotechnology company.
Filing · LD-2 quarterly report
Q2 report
Reporting period
2nd Quarter 2025
Apr 1 - June 30 · Posted Jul 15, 2025
Income
$30,000
What the client paid this registrant for the period.
Client based in
Massachusetts
Lobbyists on this filing
1
-
ALANNA TEMMEPreviously held: Legislative Director, U.S. Representative Jon Porter
Government bodies contacted
4
Lobbying activity
1
FDA process issues. H.R.1262/S.932 - Give Kids a Chance Act of 2025.